Skip to main content

Editas Medicine, Inc 10-Q for FY2025 Q1

Editas Medicine, Inc. (EDIT)

10-Q 2025-05-12 For: 2025-03-31
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on May 12, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).

Headline figures

Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$4.66M
up 310.4% from $1.14M a year earlier
Net loss
$76.09M
compared with a net loss of $61.95M a year earlier
Diluted EPS
-$0.92
compared with -$0.76 a year earlier